{
  "Variants Include": [
    {
      "Gene": "SMN1",
      "variants": [
        {
          "HGVS": "NM_000377.3:c.1234A>T",
          "cDNA Change": {
            "transcript": "NM_000377.3",
            "ref": "A",
            "alt": "T",
            "position": "1234"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "1234"
          },
          "Description in input context": "The c.1234A>T variant results in a premature stop codon and reduced SMN protein levels."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Spinal Muscular Atrophy",
    "MONDO": "MONDO:0003911"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Patient-Derived Material",
        "Material Name": "Fibroblasts from SMA patients",
        "Description": "Fibroblasts were isolated from skin biopsies of SMA patients carrying the c.1234A>T variant."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000377.3:c.1234A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "SMN protein levels were reduced by approximately 80% in fibroblasts carrying the c.1234A>T variant compared to control fibroblasts."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent fibroblast cultures from different SMA patients were used as biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Fibroblasts from a healthy donor were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "No explicit negative control was used."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "SMN protein expression between 80% and 120% of control values.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "SMN protein expression below 80% of control values.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "RT-qPCR",
      "Material used": {
        "Material Source": "Patient-Derived Material",
        "Material Name": "Fibroblasts from SMA patients",
        "Description": "Total RNA was extracted from fibroblasts using TRIzol reagent."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000377.3:c.1234A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "altered splicing",
          "Result Description": "The expression of the SMN2 transcript was significantly increased in fibroblasts carrying the c.1234A>T variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent fibroblast cultures from different SMA patients were used as biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "RNA from a healthy donor was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "No explicit negative control was used."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One-way ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "SMN2 transcript expression between 1.0 and 1.5 relative to control values.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "SMN2 transcript expression greater than 1.5 relative to control values.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}